Patient P-01316

Synthetic patientNBL-101 · Day 117 · 55–64 · F · baseline S10Steering view · 3D Open companion preview

Therapy response

Improving

Tolerance

Deteriorating

GI state

Improving

Inflammatory state

Improving

Nutritional resilience

Improving

Discontinuation risk

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 NBL-101 started — Baseline state S10
Day 16 Trajectory diverged from prediction — Observed response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 16.

Primary contributors, last 14 days

Treatment adherence+10
GI instability-9
Inflammatory activity-8
Nutritional resilience+7
Toxicity+7

What helped?

No interventions yet.

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

GI burden

Companion

9.6/100

improving · -3.1 vs previous 14 d

Toxicity

Blood

21.5/100

stable · +0.6 vs previous 14 d

Sleep quality

Wearable

55/100

stable · +1.0 vs previous 14 d

Energy level

Daily log

7/10

stable · -0.1 vs previous 14 d

Stress level

Daily log

3.3/10

stable · +0.0 vs previous 14 d

Steps

Wearable

7,541

improving · +527 vs previous 14 d

Adherence

Companion

99.5 %

stable · +0.5 vs previous 14 d

This trajectory is decaying — what would help, what would not

Steering view →

Heading towards restoration · 92 from the failing basin, 9 from restoration.

Would help

No untried action with strong evidence. Compose one from primitives.

Would not help

HY-01 Hydration Protocol
only 44% improved among 9 similar
Keep alcohol low
GI +2.5 next day on high-intake days · n 15

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Alcohol
+2.5detractor · 88%
Insoluble fibre
-0.9no signal · 33%
Spicy / capsaicin
+0.8no signal · 27%
Dietary fat load
+0.6no signal · 21%
Simple carbohydrates
+0.4no signal · 15%
Histamine load
-0.1no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

DNA

Fictional pharmacogenomic panel

CYP2D6 Normal metabolizer
Expected exposure

Microbiome

Shannon diversity 3.6 · butyrate capacity 74/100

Akkermansia muciniphilaNormal
Faecalibacterium prausnitziiNormal
Bacteroides fragilisNormal
Bifidobacterium longumNormal
EnterobacteriaceaeHigh

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 53 ms
Sleep: 7.1 h
Steps: 7,501
Resting HR: 58 bpm

Daily log: GI score 10, nutritional resilience 72, adherence 100.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Keep fibre steady; no new sources this week
Avoid known triggers for now: fried or oily food, dairy, alcohol

What to do

Log the daily check-in; one line is enough
Keep the current walking rhythm
Keep the sleep window steady
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the scheduled dose as agreed with your care team
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-01479	41%	S15	DT-01	improved	84
P-01467	40%	S09	HY-01	improved	79
P-01855	40%	S04	DT-01	improved	73
P-01439	39%	S18	ME-01	improved	79
P-01625	39%	S06	SC-12	improved	83
P-01503	38%	S15	ME-01	improved	80
P-01724	38%	S10	DT-01	improved	63
P-01329	37%	S08	BR-03	improved	79
P-01796	37%	S09	SC-12	improved	86
P-01671	36%	S04	SC-12	improved	90
P-01798	35%	S08	NP-02	improved	78
P-01654	34%	S08	CR-01	improved	85